Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could cutting certain foods calm Children's gut inflammation?

NCT ID NCT07779772

Knowledge-focused Sponsor: Cukurova University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study follows children aged 2-17 with eosinophilic gastrointestinal disorders (EGID) to see how elimination diets—removing foods like milk, eggs, or wheat—affect their symptoms and gut healing. Doctors choose the diet as part of routine care, and researchers track clinical and biopsy results over time. The goal is to understand which dietary approaches may lead to remission and how food reintroduction affects disease recurrence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Elimination diet (removing foods like milk, egg, soy, wheat, nuts, and seafood)
What this could lead to
If successful, this could help identify which dietary strategies work best for children with EGID, potentially guiding more effective and less restrictive treatment plans.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by natural disease fluctuations and differences in how doctors prescribe diets.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 34 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children aged 2-17 years evaluated at the Pediatric Gastroenterology Unit of Cukurova University who undergo gastrointestinal endoscopy for clinical indications and are diagnosed with an eosinophilic gastrointestinal disorder based on clinical and histologic findings after exclusion of other relevant causes of gastrointestinal eosinophilia.

Ages

2 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 2-17 years. * Presence of gastrointestinal symptoms such as abdominal pain, vomiting, diarrhea, hematemesis, or hematochezia. * Undergoing upper and/or lower gastrointestinal endoscopy for a clinical indication. * Histologic eosinophilic infiltration consistent with an eosinophilic gastrointestinal disorder. * Exclusion of other relevant causes of gastrointestinal eosinophilia. Exclusion Criteria: * Inflammatory bowel disease, parasitic infection, celiac disease, drug-associated enteropathy, hypereosinophilic syndrome, or other identified causes of gastrointestinal eosinophilia. * Known primary immunodeficiency. * Active malignancy. * Systemic rheumatologic disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eosinophilic gastrointestinal disorders (EGID) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

eosinophilic esophagitis eosinophilic gastrointestinal disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eosinophilic gastrointestinal disorders (EGID)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cukurova University Balcali Hospital

    RECRUITING

    Adana, Sarıcam, 01330, Turkey (Türkiye)